Elias Dominique, Santoro Roberto, Ouellet Jean-Francois, Osmak Liliana, de Baere Thierry, Roche Alain
Department of Surgical Oncology, Institut Gustave Roussy, Villejuif, France.
Hepatogastroenterology. 2004 Nov-Dec;51(60):1788-91.
BACKGROUND/AIMS: Hepatic resection offers the best chance of survival for patients with liver metastases (LM) of colorectal origin. However, some patients are not eligible for surgery because of a too small future liver remnant (FLR) which carries a high risk of severe postoperative liver failure. The operability status of these patients can be favorably changed by selective right portal vein embolization (PVE) which induces compensatory growth of the left liver. However, during liver regeneration following right PVE, the left LM growth rate is faster than that of the non-embolized normal liver parenchyma. This study aimed at examining an approach for those patients in which there is bilateral LM potentially resectable following portal vein embolization, but in which there is a risk of rapid liver metastasis growth in the non-embolized liver.
Between October 1998 and January 2001, 5 patients underwent simultaneous right PVE and radiofrequency ablation (RFA) of a left LM, prior to a major right-sided hepatectomy for initially unresectable bilateral LM. All these patients had one LM in the left liver in addition with multiple LM in the right liver. Simultaneous right PVE and left RFA was performed percutaneously under intravenous sedation and analgesia. One month later, hepatectomy was undertaken. To allow histologic assessment of the RFA effectiveness, the previously treated left-sided tumor was also resected and analyzed.
Simultaneous PVE-RFA was successful in all patients. No tumor growth on the RFA site was observed during the interval between PVE-RFA and surgery. Histologic examination showed complete tumor sterilization of the RFA necrotic zone. In the postoperative course, 1 patient died of acute liver failure. For the 4 remaining patients, morbidity was minimal (transient bile leak in one patient).
Simultaneous percutaneous right PVE and left RFA is feasible. This procedure allowed good left-sided tumor control during liver growth following PVE in all five patients. It is the most logical procedure for patients with bilateral colorectal LM needing right PVE before resection, if the left concomitant LM is small and accessible to percutaneous RFA. This procedure should be preferred because it eliminates the risk of left LM growth during the 1-month interval between PVE and surgery.
背景/目的:肝切除为结直肠癌肝转移(LM)患者提供了最佳的生存机会。然而,一些患者因未来肝残余量(FLR)过小而不符合手术条件,这会带来严重术后肝衰竭的高风险。选择性右门静脉栓塞术(PVE)可诱导左肝代偿性生长,从而有利地改变这些患者的可手术状态。然而,在右PVE后的肝再生过程中,左肝转移瘤的生长速度比未栓塞的正常肝实质更快。本研究旨在探讨一种针对门静脉栓塞后双侧LM可能可切除,但未栓塞肝脏存在肝转移快速生长风险的患者的治疗方法。
1998年10月至2001年1月期间,5例患者在因最初不可切除的双侧LM接受右侧大肝切除术前,同时接受了右PVE和左肝转移瘤的射频消融(RFA)。所有这些患者左肝有一个转移瘤,右肝有多个转移瘤。在静脉镇静和镇痛下经皮进行右PVE和左RFA。1个月后进行肝切除术。为了对RFA疗效进行组织学评估,还切除并分析了先前治疗的左侧肿瘤。
所有患者的PVE-RFA均成功。在PVE-RFA与手术之间的间隔期内,未观察到RFA部位的肿瘤生长。组织学检查显示RFA坏死区肿瘤完全灭活。术后过程中,1例患者死于急性肝衰竭。其余4例患者的并发症轻微(1例患者出现短暂胆漏)。
经皮同时进行右PVE和左RFA是可行的。该手术在所有5例患者的PVE后肝脏生长过程中实现了对左侧肿瘤的良好控制。对于双侧结直肠癌肝转移患者,如果左侧合并转移瘤较小且可经皮RFA治疗,在切除术前需要右PVE,那么该手术是最合理的方法。该手术应优先选择,因为它消除了PVE与手术之间1个月间隔期内左肝转移瘤生长的风险。